LED Medical Diagnostics Inc. develops and markets medical devices in the dental industry under the VELscope trade name in North America. Its products include Velscope Vx system, a device for the enhanced visualization of mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides diagnostic imaging products and software to dental and oral health specialists....
235–5589 Byrne Road
Burnaby, BC V5J 3J1
Founded in 2003
LED Medical Diagnostics Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017
Aug 17 17
LED Medical Diagnostics Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported revenues of USD 3,704,499 against USD 3,661,490 a year ago. Operating loss was USD 259,935 against USD 1,011,490 a year ago. Net income before income taxes was USD 905,233 against net loss before income taxes of USD 1,082,831 a year ago. Net income and comprehensive income was USD 905,233 against net loss and comprehensive loss of USD 1,082,831 a year ago. Cash flow used in operations was USD 1,096,973 against USD 820,560 a year ago. Purchase of equipment was USD 12,000.
For the six months, the company reported revenues of USD 5,802,915 against USD 5,814,740 a year ago. Operating loss was USD 1,022,324 against USD 3,006,204 a year ago. Net loss before income taxes was USD 182,728 against USD 3,134,658 a year ago. Net loss and comprehensive loss was USD 182,728 against USD 3,134,658 a year ago. Cash flow used in operations was USD 2,456,317 against USD 1,505,387 a year ago. Purchase of equipment was USD 74,284 against USD 117,670 a year ago.
LED Medical Diagnostics Inc., Annual General Meeting, Aug 22, 2017
Jun 22 17
LED Medical Diagnostics Inc., Annual General Meeting, Aug 22, 2017, at 11:00 Pacific Standard Time. Location: Farris, Vaughan, Wills & Murphy LLP, 25th Floor, 700 West Georgia Street Vancouver British Columbia Canada Agenda: To receive the audited financial statements of the Corporation for the financial year ended December 31, 2016 and the report of the auditors thereon; to appoint Grant Thornton LLP as auditors of the Corporation for the coming year and to authorize the Board of Directors to fix the auditors' remuneration; to elect the directors of the Corporation for the upcoming year; to approve the stock option plan of the Corporation; to transact such other business as may properly come before the Meeting.
LED Medical Diagnostics Inc. Announces Financial Results for the First Quarter Ended March 31, 2017
May 30 17
LED Medical Diagnostics Inc. announced financial results for the first quarter ended March 31, 2017. The company reported revenue of $2.098 million, which is a decrease of 2% from the three months ended March 31, 2016 and a 13% increase in revenues from the three months ended December 31, 2016. The net loss was $1.08 million for the three months ended March 31, 2017, as compared to a net loss of $2.05 million for the three months ended March 31, 2016. Cash flow used in operations was $1.39 million during the three months ended March 31, 2017 compared to $684,000 during the three months ended March 31, 2016.